The Effect of Use of Tricyclic Antidepressants or Serotonin‐Norepinephrine Reuptake Inhibitors Versus Selective Serotonin Reuptake Inhibitors on the Risk of Urinary Tract Infection Among People With Multiple Sclerosis: A Nested Case–Control Study
Pharmacoepidemiology and Drug Safety · 2025
DOI: 10.1002/pds.70260 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Pharmacoepidemiology and Drug Safety, 2025. Verfasst von Melissa W Y Leung und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division Pharmacoepidemiology & Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Department of Pharmaceutical Sciences, F…. Hauptthemen laut MEDLINE: Multiple Sclerosis, Antidepressive Agents, Tricyclic, Urinary Tract Infections, Selective Serotonin Reuptake Inhibitors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Purpose
To study the effect of tricyclic antidepressant (TCA)/selective serotonin‐norepinephrine reuptake inhibitor (SNRI) versus selective serotonin reuptake inhibitor (SSRI) on the risk of urinary tract infection (UTI) among people with multiple sclerosis (MS).
Methods
A case–control study was conducted using data from the UK Clinical Practice Research Datalink Aurum, nested within a cohort of people with MS. Each person with a UTI was matched to ≤ 4 controls on sex, region, age (±2 years), and time since MS diagnosis (±20%). Conditional logistic regression analyses were conducted to calculate adjusted odds ratios (aORs) with 95% confidence intervals (CIs) to compare TCA/SNRI to SSRI use and each antidepressant group to no antidepressant use. ORs were adjusted for smoking status, BMI, comorbidities, and recent drug prescriptions.
Results
Two thousand six hundred and sixty‐four cases were matched to 3722 controls. TCA/SNRI versus SSRI use did not increase the risk of UTI (conditional aOR 1.21 [95% CI: 0.84–1.75]). TCA/SNRI use versus no antidepressant use did show an increased risk (conditional aOR [95% CI: 1.43 [1.21–1.69]), but SSRI versus no use did not (conditional aOR 1.15 [0.96–1.37]).
Conclusions
This study showed no increased risk of UTI for TCA/SNRI versus SSRI use among people with MS. However, effect estimates were imprecise due to small sample sizes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division Pharmacoepidemiology & Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Department of Pharmaceutical Sciences, Faculty of Science, Utrecht University, Utrecht, the Netherlands.
- Department of Pharmacy, Sint Antonius Hospital, Utrecht/Nieuwegein, the Netherlands.
- Department of Neurology, MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam University Medical Center, Amsterdam, the Netherlands.
ORCID-Profile: Melissa W Y Leung, Ewoudt M W van de Garde, Bernard M J Uitdehaag, Patrick C Souverein, Marloes T Bazelier
Zitieren
APA
Leung, M. W. Y., van de Garde, E. M. W., Uitdehaag, B. M. J., Souverein, P. C., Klungel, O. H., & Bazelier, M. T. (2025). The Effect of Use of Tricyclic Antidepressants or Serotonin‐Norepinephrine Reuptake Inhibitors Versus Selective Serotonin Reuptake Inhibitors on the Risk of Urinary Tract Infection Among People With Multiple Sclerosis: A Nested Case–Control Study. Pharmacoepidemiology and Drug Safety. https://doi.org/10.1002/pds.70260
Vancouver
Leung MWY, van de Garde EMW, Uitdehaag BMJ, Souverein PC, Klungel OH, Bazelier MT. The Effect of Use of Tricyclic Antidepressants or Serotonin‐Norepinephrine Reuptake Inhibitors Versus Selective Serotonin Reuptake Inhibitors on the Risk of Urinary Tract Infection Among People With Multiple Sclerosis: A Nested Case–Control Study. Pharmacoepidemiology and Drug Safety. 2025. doi:10.1002/pds.70260
BibTeX
@article{Leung2025,
author = {Leung, Melissa W Y and van de Garde, Ewoudt M W and Uitdehaag, Bernard M J and Souverein, Patrick C and Klungel, Olaf H and Bazelier, Marloes T},
title = {The Effect of Use of Tricyclic Antidepressants or Serotonin‐Norepinephrine Reuptake Inhibitors Versus Selective Serotonin Reuptake Inhibitors on the Risk of Urinary Tract Infection Among People With Multiple Sclerosis: A Nested Case–Control Study},
journal = {Pharmacoepidemiology and Drug Safety},
year = {2025},
doi = {10.1002/pds.70260}
}
EUVIMED